Adicet Bio Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies ...

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Evidence of efficacy and safety data support the potential for vatiquinone to fill the significant unmet need for patients ...

A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...

Prasinezumab continues to be well tolerated and no new safety signals were observed.

Biomedicines as part of its efforts to drive growth and innovation in the biopharmaceutical sector. Established in 2021 and ...

With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and ...

Partnership leverages PHICS technology to bring together a kinase and target of interest to modulate protein function.

Hansoh Pharma will receive $112 million upfront and is eligible to receive up to $1.9 billion in milestone payments.

Novo Nordisk will soon acquire from Novo Holdings Catalent’s three fill-finish sites located in Italy, the U.S., and Belgium.

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of mechanisms of action. Adds Nimble's lead asset and a pipeline of other novel ...